BEAM vs BLK · rev $63.5M vs P/E 27, rev $24.22B
Beam Therapeutics Inc (BEAM) versus BlackRock Inc (BLK) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
BEAM currently screens at market cap $2.01B. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Not investment advice. Open the BEAM and BLK stock pages for the full models.
Not investment advice.